| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,004 |
12,837 |
$1.10M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,240 |
5,706 |
$364K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
1,494 |
1,155 |
$30K |
| 99051 |
|
2,851 |
2,541 |
$19K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,222 |
809 |
$13K |
| 99307 |
|
1,678 |
1,038 |
$13K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
170 |
133 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,183 |
2,888 |
$7K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,657 |
1,380 |
$6K |
| 99215 |
Prolong outpt/office vis |
41 |
39 |
$6K |
| 87428 |
|
826 |
432 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
982 |
766 |
$752.94 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
27 |
26 |
$440.00 |
| G0008 |
Administration of influenza virus vaccine |
67 |
46 |
$287.28 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,514 |
1,513 |
$208.93 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,482 |
1,183 |
$161.90 |
| 81003 |
|
202 |
182 |
$155.96 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
135 |
87 |
$108.25 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
484 |
315 |
$1.19 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
790 |
717 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
154 |
131 |
$0.00 |
| J2010 |
Injection, lincomycin hcl, up to 300 mg |
225 |
193 |
$0.00 |
| 81025 |
|
14 |
13 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
58 |
50 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
42 |
41 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
101 |
94 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
16 |
14 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
63 |
40 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
18 |
13 |
$0.00 |
| 81000 |
|
218 |
172 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
150 |
132 |
$0.00 |
| 87807 |
|
188 |
162 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
52 |
51 |
$0.00 |
| 90686 |
|
27 |
17 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
29 |
25 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
21 |
12 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
206 |
185 |
$0.00 |